Nearly all patients with brain metastases have limited eligibility to participate in most clinical trials. This restriction of access will hinder the systemic therapy improvements needed for all ...

Six hundred trials from high-impact medical journals were classified depending on whether they allowed for the inclusion of patients with localized and/or metastatic disease. Five hundred trials were ...

Despite constituting the largest minority group in the U.S. and expressing interest in participating in clinical trials, people with disabilities remain excluded. A new study led by investigators from ...